RT @NeurologyToday: Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
RT @NeurologyToday: Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
RT @NeurologyToday: Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
RT @NeurologyToday: Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
RT @NeurologyToday: Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
RT @NeurologyToday: Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
Rituximab was effective and well tolerated in patients with MS and neuromyelitis optica https://t.co/345dZIUbKT #MS #NMO
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica:… https://t.co/9PAdCCt9ko
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica:… https://t.co/kWZEhDUU0K